# Fluorescent Intra-operative Tumor Margin Examination

> **NCT04719156** · PHASE2 · RECRUITING · sponsor: **Kurt Weiss** · enrollment: 110 (estimated)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** Indocyanine green solution administered at 2.0mg/kg.
- **DEVICE:** Stryker SPY-PHI Imaging Device

## Key facts

- **NCT ID:** NCT04719156
- **Lead sponsor:** Kurt Weiss
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-02
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04719156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04719156, "Fluorescent Intra-operative Tumor Margin Examination". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04719156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*